The MSL and LAR subtypes had higher PI3K pathway activation scores: MSL TNBC are driven by low levels of PTEN protein and LAR TNBC, like other luminal breast cancers, are driven by high levels of PI3K protein (Figure 3B). The gene discussed is PTEN; the disease is breast cancer.